{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:51:56Z","timestamp":1761623516490,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bioscience and Bioengineering"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbiosc.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:46:50Z","timestamp":1757015210000},"page":"421-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sterilizable autoantigen immobilized column platform for broad-spectrum removal of pathogenic autoantibodies in autoimmune diseases"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0762-2678","authenticated-orcid":false,"given":"Midori","family":"Futami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudai","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0020-2855","authenticated-orcid":false,"given":"Junichiro","family":"Futami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiosc.2025.08.007_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.transci.2017.08.011","article-title":"Immunoadsorption using immusorba TR and PH","volume":"56","author":"Hirano","year":"2017","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1744-9987.1998.tb00102.x","article-title":"Immusorba TR and Immusorba PH: basics of design and features of functions","volume":"2","author":"Yoshida","year":"1998","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1526-0968.2003.00010.x","article-title":"Immusorba TR and PH","volume":"7","author":"Hirata","year":"2003","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfr610","article-title":"Anti-A\/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorption","volume":"27","author":"Wahrmann","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000090659","article-title":"Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption","volume":"212","author":"Eming","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jbiosc.2025.08.007_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1526-0968.2003.00017.x","article-title":"Peptide based adsorbers for therapeutic immunoadsorption","volume":"7","author":"R\u00f6nspeck","year":"2003","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1526-0968.2001.00367.x","article-title":"Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor","volume":"5","author":"Takamori","year":"2001","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-016-0678-4","article-title":"Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system","volume":"13","author":"Sinmaz","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jbiosc.2025.08.007_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","volume":"190","author":"Kostelidou","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2012.06788.x","article-title":"Antigen-specific apheresis of autoantibodies in myasthenia gravis","volume":"1275","author":"Lazaridis","year":"2012","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2014.09.013","article-title":"Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy","volume":"276","author":"Skriapa","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1196\/annals.1405.017","article-title":"Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera","volume":"1132","author":"Tzartos","year":"2008","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients\u2019 sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.jbiosc.2025.08.007_bib15","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1021\/bi052642a","article-title":"Denatured and reversibly cationized p53 readily enters cells and simultaneously folds to the functional protein in the cells","volume":"45","author":"Murata","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbiosc.2025.08.007_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jbiosc.2016.11.011","article-title":"Enhanced in-cell folding of reversibly cationized transcription factor using amphipathic peptide","volume":"123","author":"Futami","year":"2017","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12748-y","article-title":"Evaluation of irreversible protein thermal inactivation caused by breakage of disulphide bonds using methanethiosulphonate","volume":"7","author":"Futami","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib18","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/acs.bioconjchem.5b00328","article-title":"Sensitive multiplexed quantitative analysis of autoantibodies to cancer antigens with chemically S-cationized full-length and water-soluble denatured proteins","volume":"26","author":"Futami","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"Pt 3","key":"10.1016\/j.jbiosc.2025.08.007_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1470-8744.1998.tb00531.x","article-title":"A new derivatizing agent, trimethylammoniopropyl methanethiosulphonate, is efficient for preparation of recombinant brain-derived neurotrophic factor from inclusion bodies","volume":"28","author":"Inoue","year":"1998","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0021-9258(18)70197-X","article-title":"Reaction of ethylene oxide with histidine, methionine, and cysteine","volume":"234","author":"Windmueller","year":"1959","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jps.24257","article-title":"Chemical modifications of therapeutic proteins induced by residual ethylene oxide","volume":"104","author":"Chen","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.869393","article-title":"Engineering cancer\/testis antigens with reversible","volume":"12","author":"Miyamoto","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3532","article-title":"Pre-folding purification procedures for inclusion body-derived non-tagged cationic recombinant proteins with multiple disulfide bonds for efficient refolding","volume":"41","author":"Kimura","year":"2025","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/oxfordjournals.jbchem.a124606","article-title":"An S-alkylating reagent with positive charges as an efficient solubilizer of denatured disulfide-containing proteins","volume":"116","author":"Yamada","year":"1994","journal-title":"J. Biochem."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1325171","article-title":"A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression","volume":"15","author":"Koneczny","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fimmu.2020.00613","article-title":"Long-lasting rituximab-induced reduction of specific-but not total-IgG4 in MuSK-positive myasthenia gravis","volume":"11","author":"Marino","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib27","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/rheumatology\/kead397","article-title":"The central helicase domain holds the major conformational epitopes of melanoma differentiation-associated gene 5 autoantibodies","volume":"63","author":"Mo","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbiosc.2025.08.007_bib28","doi-asserted-by":"crossref","first-page":"30578","DOI":"10.1074\/jbc.M114.582221","article-title":"Identification of a point mutation impairing the binding between aquaporin-4 and neuromyelitis optica autoantibodies","volume":"289","author":"Pisani","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2e462817-ab93-4d78-95a4-1d8b9d172971","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiosc.2025.08.007_bib30","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.3390\/ijms25147666","article-title":"Understanding autoimmunity: mechanisms, predisposing factors, and cytokine therapies","volume":"25","author":"Yasmeen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.1998.tb01217.x","article-title":"Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis","volume":"164","author":"Vincent","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mehy.2016.11.021","article-title":"Are linear AChR epitopes the real culprit in ocular myasthenia gravis?","volume":"99","author":"Wu","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jbiosc.2025.08.007_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41584-019-0254-2","article-title":"T follicular helper cells and T follicular regulatory cells in rheumatic diseases","volume":"15","author":"Deng","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1254.026","article-title":"Scenarios for autoimmunization of T and B cells in myasthenia gravis","volume":"998","author":"Shiono","year":"2003","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.jbiosc.2025.08.007_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1158\/2326-6066.CIR-14-0029","article-title":"Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses","volume":"2","author":"Eisen","year":"2014","journal-title":"Cancer Immunol. Res."}],"container-title":["Journal of Bioscience and Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138917232500221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138917232500221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:46:01Z","timestamp":1761623161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138917232500221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S138917232500221X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiosc.2025.08.007","relation":{},"ISSN":["1389-1723"],"issn-type":[{"type":"print","value":"1389-1723"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sterilizable autoantigen immobilized column platform for broad-spectrum removal of pathogenic autoantibodies in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Bioscience and Bioengineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiosc.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Society for Biotechnology, Japan. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}